Literature DB >> 22459173

Binding of quinidine radically increases the stability and decreases the flexibility of the cytochrome P450 2D6 active site.

Karel Berka1, Eva Anzenbacherová, Tereza Hendrychová, Reinhard Lange, Vlastimil Mašek, Pavel Anzenbacher, Michal Otyepka.   

Abstract

Human cytochrome P450 2D6 (CYP2D6) is an enzyme of the CYP superfamily responsible for biotransformation of about 20% of drugs of known metabolism containing a basic nitrogen and a planar aromatic ring. Here, we present a combined experimental and computational study on the compressibility and flexibility of unliganded and quinidine-bound CYP2D6. Experimentally, high-pressure induced Soret band shifts of the enzyme were measured by UV/VIS spectroscopy, while 100 ns all atomic molecular dynamics (MD) simulations in explicit water were used in the computational analysis. We identified sharp differences between ligand-free and quinidine-bound CYP2D6 forms in compressibility, flexibility parameters and active site solvation. While the unliganded CYP2D6 is compressible, quinidine binding significantly rigidifies the CYP2D6 active site. In addition, MD simulations show that quinidine binding results in pronounced reductions in active site flexibility and solvation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22459173     DOI: 10.1016/j.jinorgbio.2012.02.010

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  7 in total

Review 1.  Predicting drug metabolism: experiment and/or computation?

Authors:  Johannes Kirchmair; Andreas H Göller; Dieter Lang; Jens Kunze; Bernard Testa; Ian D Wilson; Robert C Glen; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2015-04-24       Impact factor: 84.694

2.  Divergent evolution of ligand binding in the o-succinylbenzoate synthase family.

Authors:  Denis Odokonyero; Sugadev Ragumani; Mariana S Lopez; Jeffrey B Bonanno; Nicole D S Ozerova; Danae R Woodard; Benjamin W Machala; Subramanyam Swaminathan; Stephen K Burley; Steven C Almo; Margaret E Glasner
Journal:  Biochemistry       Date:  2013-10-09       Impact factor: 3.162

3.  Charge-transfer interaction of drug quinidine with quinol, picric acid and DDQ: Spectroscopic characterization and biological activity studies towards understanding the drug-receptor mechanism.

Authors:  Hala H Eldaroti; Suad A Gadir; Moamen S Refat; Abdel Majid A Adam
Journal:  J Pharm Anal       Date:  2013-07-10

4.  Microsecond MD simulations of human CYP2D6 wild-type and five allelic variants reveal mechanistic insights on the function.

Authors:  Charleen G Don; Martin Smieško
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

5.  Drug-Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats.

Authors:  Qiong Wang; Haiyun Wang; Youyan Zhong; Qiang Zhang
Journal:  Drug Des Devel Ther       Date:  2019-12-12       Impact factor: 4.162

6.  Dynamics and flexibility of human aromatase probed by FTIR and time resolved fluorescence spectroscopy.

Authors:  Giovanna Di Nardo; Maximilian Breitner; Sheila J Sadeghi; Silvia Castrignanò; Giampiero Mei; Almerinda Di Venere; Eleonora Nicolai; Paola Allegra; Gianfranco Gilardi
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

7.  Molecular dynamics of CYP2D6 polymorphisms in the absence and presence of a mechanism-based inactivator reveals changes in local flexibility and dominant substrate access channels.

Authors:  Parker W de Waal; Kyle F Sunden; Laura Lowe Furge
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.